Clinical Trials in Texas

Showing 9361-9380 of 11,487 trials

Safety Study for the Treatment of Abdominal Aortic Aneurysms

NCT00610090

The primary study objective, at this time, is to follow out to 5 years post implant the safety of already enrolled subjects who were treated with the UniFit Aorto-uni-iliac (AUI) Endoluminal Stent Graft (the "study device") for the repair of abdominal aortic aneurysms (AAAs).

Abdominal Aortic Aneurysms

Duke Vascular, Inc.71 participantsStarted May 2007

Loma Linda, California, United States • Torrance, California, United States • Newark, Delaware, United States +16 more locations

COMPLETEDPhase 255 miles

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

NCT01462695

This phase II trial studies how well sunitinib malate works in treating younger patients with recurrent, refractory, or progressive malignant glioma or ependymoma. Sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Childhood Cerebellar Anaplastic AstrocytomaChildhood Cerebral Anaplastic AstrocytomaChildhood Cerebral Astrocytoma+8 more

National Cancer Institute (NCI)30 participantsStarted Jan 2012

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Little Rock, Arkansas, United States +93 more locations

Safety Study for the Treatment of Abdominal Aortic Aneurysms

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Find Trials by Condition in Texas

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

Phase III Study in Refractory Behcet's Disease

Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Effect of Febuxostat on Blood Pressure

huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Gadobutrol Enhanced MRA of the Renal Arteries

Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors

A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

Multiple Ascending Dose (MDX1105-01)

fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Surgical Reduction of the Inferior Turbinates for Nasal Obstruction